Watch, LLC, the IV safety company, today announced it has submitted a 510(k) filing to the U.S. Food and Drug Administration (FDA) for its SmartTouch+™ Sensor, expanding the company's IV monitoring ...

Disruptive innovation provides NHS Trusts faster access to continuous IV monitoring to reduce avoidable extravasation harm NEWPORT NEWS, Va. and LONDON, July 22, 2026 /PRNewswire/ -- ivWatch, the IV ...

Self-advocacy is crucial in healthcare, especially for patients with chronic conditions like cancer, to ensure proper care and treatment. Recognizing signs of IV infiltration and extravasation is ...

ivWatch just announced winning the European CE Mark for its ivWatch Model 400 device, the only continuous monitor for timely detection of intravenous (IV) infiltrations and extravasations. IV ...

Hampton Roads-based medical device company ivWatch, LLC racked up several prestigious recognitions and awards this year for its innovative work in enhancing IV safety. The company, headquartered in ...